Loading...
Market
What will happen to Alchem International's market share in the pharmaceutical sector by end of 2024?
5
Resolution / Starting Odds
Increases • 33%
Decreases • 33%
Remains the same • 33%
Market analysis reports from reputable industry analysts
Story
EU Regulators Accuse Indian Drugmaker Alchem of Price-Fixing in Pharmaceutical Cartel
Jun 13, 2024, 09:49 AM
EU antitrust regulators have issued a formal statement of objections to Alchem International on Thursday, accusing the Indian drugmaker of participating in a pharmaceutical cartel to fix prices of a key ingredient used in drugs for stomach complaints. The allegations suggest that Alchem conspired with its rivals to manipulate the market for this essential component, leading to potentially higher costs for consumers. The formal complaint marks a significant step in the EU's ongoing efforts to combat anti-competitive practices in the pharmaceutical industry.
View original story
Similar markets
Increase • 33%
No significant change • 33%
Decrease • 33%
Less than 20% • 25%
20%-40% • 25%
40%-60% • 25%
More than 60% • 25%
Ozempic gains over 30% market share • 25%
Ozempic gains 10-30% market share • 25%
Ozempic gains less than 10% market share • 25%
Ozempic loses market share • 25%
Increase in market share • 33%
No change in market share • 34%
Decrease in market share • 33%
Decrease by more than 10% • 25%
Decrease by less than 10% • 25%
Remain stable • 25%
Increase • 25%
Less than 10% • 33%
10% to 20% • 33%
More than 20% • 33%
Increase by more than 5% • 33%
Remain within ±5% • 33%
Decrease by more than 5% • 33%
Top 10 globally • 25%
Top 50 globally • 25%
No significant change • 25%
Loses market position • 25%
Increase in sales • 33%
Decrease in sales • 33%
No significant change • 34%
Top 10 • 25%
Top 20 • 25%
Top 30 • 25%
Below Top 30 • 25%
Increase in drug prices • 33%
Decrease in drug availability • 33%
No significant change • 34%
